startups digital health weight loss glp-1 platforms What's next for innovation: A primer on the race reshaping pharma and chronic disease care The unknown trajectory of GLP-1 – Digital health companies are launching

The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging: Mechanisms and therapeutic potential

Each fills gaps the other cannot address alone

Fighting Inflammation & Supporting Longevity GLP-1 medications are showing potential in reducing chronic inflammation , which is linked to aging and many diseases

Microneedle transdermal patches can potentially deliver the following benefits and more, if research and trials show feasible results: Further advancement in the transdermal patch landscape could lead to the manufacturing of multi-reservoir patches, delivering numerous active ingredients at different rates

The hair pull test, where a clinician gently pulls on a cluster of about 60 hairs, will yield six or more hairs in active telogen effluvium, compared to one or two normally